Clinical Trial Detail

NCT ID NCT03042910
Title A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Medivation, Inc.
Indications

Advanced Solid Tumor

Therapies

Talazoparib

Age Groups: senior adult

No variant requirements are available.